文献速递角膜与眼表疾病

自体血清滴眼液治疗眼表疾病:美国眼科学会报告

Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2019-09-24

该报告基于PubMed和Cochrane图书馆截至2019年3月的文献检索,纳入13项研究(8项II级、5项III级,无I级),评估自体血清滴眼液治疗重度干眼和持续性角膜上皮缺损的安全性与有效性。多项研究显示症状或体征有改善,不良事件罕见;但因缺乏对照试验,结论受限。

要点

  • 自体血清滴眼液治疗重度干眼的研究中,8项报告症状改善,所有研究至少1项临床体征改善。
  • 持续性角膜上皮缺损的4项研究中全部显示改善,其中3项改善率超过90%。
  • 不良事件罕见,但无I级研究,且缺乏对照试验限制结论。

核心结论

  • 自体血清滴眼液可能对重度干眼和持续性角膜上皮缺损有效,但因缺乏对照试验,结论受限。

研究设计与样本

  • 美国眼科学会报告,通过PubMed和Cochrane图书馆检索截至2019年3月的文献,初检281篇,全文评审48篇,最终纳入13项研究(8项II级、5项III级,无I级)。

主要发现

  • 分析纳入10项重度干眼研究和4项持续性角膜上皮缺损研究。
  • 重度干眼中8项研究报告症状改善,所有研究至少1项临床体征改善。
  • 持续性角膜上皮缺损的4项研究均显示改善,其中3项改善率超过90%。
  • 不良事件罕见。

局限性

  • 缺乏对照试验,结论受限。
  • 无I级研究,8项为II级、5项为III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the safety and effectiveness of using autologous serum-based eye drops for the treatment of severe dry eye and persistent corneal epithelial defect. METHODS: Literature searches of the PubMed and Cochrane Library databases were conducted most recently in March 2019. The searches identified 281 citations, which were reviewed in abstract form. Of these, 48 were selected for a full-text review, and 13 met the inclusion criteria and were assigned a quality-of-evidence rating by the panel methodologist. Eight of these studies were rated level II and 5 were rated level III; there were no level I studies. RESULTS: This analysis included 10 studies of the use of autologous serum-based eye drops for severe dry eye disease and 4 studies of persistent epithelial defect. Several studies showed good effectiveness, with some improvement in symptoms, signs, or both. Eight of the studies reported improved symptoms for severe dry eye disease, and all noted improvement in at least 1 clinical sign. For persistent epithelial defects, all of the studies showed improvement, with 3 of the 4 demonstrating an improvement rate of more than 90%. Adverse events were rare. CONCLUSIONS: Although autologous serum-based tears may be effective in the treatment of severe dry eye and persistent epithelial defect, conclusions are limited owing to the absence of controlled trials.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Shtein RM, Shen JF, Kuo AN, et al. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019. PMID: 31561880. doi:10.1016/j.ophtha.2019.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。